A literature review on optic neuritis following vaccination against virus infections

Autoimmunity Reviews

Volumn 12, Issue 10, 2013, Pages 990-997

  Stübgen, Joerg Patrick ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Anti virus vaccine; Autoimmune; Optic neuritis; Post vaccination

Indexed keywords

AQUAPORIN 4 ANTIBODY; HEPATITIS B VACCINE; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; T LYMPHOCYTE RECEPTOR; WART VIRUS VACCINE;

AGE DISTRIBUTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ASEPTIC MENINGITIS; AUTOIMMUNITY; CEREBELLAR ATAXIA; CLINICAL FEATURE; COST BENEFIT ANALYSIS; DEMYELINATION; DISEASE COURSE; DRUG SAFETY; FOLLOW UP; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HEALTH MAINTENANCE ORGANIZATION; HUMAN; IMMUNIZATION; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; MYELOOPTIC NEUROPATHY; NONHUMAN; ONSET AGE; OPTIC NEURITIS; POSTMARKETING SURVEILLANCE; REVIEW; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; VACCINATION; VIRUS INFECTION;

ANTI-VIRUS VACCINE; AUTOIMMUNE; OPTIC NEURITIS; POST-VACCINATION;

HUMANS; OPTIC NEURITIS; RETROSPECTIVE STUDIES; VIRAL VACCINES;

EID: 84880632897     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.03.012     Document Type: Review

References (126)

1. Pau D., Al Zubidi N., Yalamanchili S., Plant G.T., Lee A.G. Optic neuritis. Eye (Lond) 2011, 25:833-847.
2. Hoorbakht H., Bagherkashi F. Optic neuritis, its differential diagnosis and management. Open Ophthalmol J 2012, 6:65-72.
3. Percy A.K., Nobrega F.T., Kurland L.T. Optic neuritis and multiple sclerosis. An epidemiologic study. Arch Ophthalmol 1972, 87:135.
4. Arnold A.C. Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol 2005, 139:1101-1108.
5. Kinnunen E. The incidence of optic neuritis and its prognosis for multiple sclerosis. Acta Neurol Scand 1983, 68:371-377.
6. Rodriguez M., Siva A., Cross S.A., O'Brien P.C., Kurland L.T. Optic neuritis: a population based study in Olmsted County, Minnesota. Neurology 1995, 45:244-250.
7. Vaphiades M.S., Kline L.B. Optic neuritis. Compr Ophthalmol Update 2007, 8:67-75.
8. El-Dairi M.A., Ghasia F., Bhatti M.T. Pediatric optic neuritis. Int Ophthalmol Clin 2012, 52:29-49.
9. Langer-Gould A., Zhang J.L., Chung J., Yeung Y., Waubant E., Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology 2011, 77:1143-1148.
10. Davis L.E. Nervous system complications of systemic viral infections. Neurology and general medicine 2008, 827-850. Churchill Livingston Elsevier, Philadelphia. 4th ed. M.J. Aminoff (Ed.).
11. Lai C.C., Chang Y.S., Li M.L., Chang C.M., Huang F.C., Tseng S.H. Acute anterior uveitis and optic neuritis as ocular complications of influenza a infection in an 11-year-old boy. J Pediatr Ophthalmol Strabismus Jul 6 2011, 48. [Online:e30-3].
12. Strong L.E., Henderson J.W., Gangitano J.L. Bilateral retrobulbar neuritis secondary to mumps. Am J Ophthalmol 1974, 78:331-332.
13. Stergiou P.K., Konstantinou I.M., Karagianni T.N., Kavaki D., Printza N.G. Optic neuritis caused by varicella infection in an immunocompetent child. Pediatr Neurol 2007, 37:138-139.
14. Azevedo A.R., Simões R., Silva F., Pina S., Santos C., Pêgo P., et al. Optic neuritis in an adult with chickenpox. Case Rep Ophthalmol Med 2012, 2012:371584.
15. Park K.H., Bang J.H., Park W.B., Kim H.B., Kim N.J., Ahn J.K., et al. Retrobulbar optic neuritis and meningoencephalitis following progressive outer retinal necrosis due to CMV in a patient with AIDS. Infection 2008, 36:475-479.
16. Ogata N., Koike N., Yoshikawa T., Takahashi K. Human herpesvirus 6-associated uveitis with optic neuritis diagnosed by multiplex PCR. Jpn J Ophthalmol 2011, 55:502-505.
17. Pickens S., Sangster G. Retrobulbar neuritis and infectious mononucleosis. Br Med J 1975, 4:729.
18. Purvin V., Herr G.J., De Myer W. Chiasmal neuritis as a complication of Epstein-Barr virus infection. Arch Neurol 1988, 45:458-460.
19. Gal R.L., Vedula S.S., Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev 2012, 4:CD001430.
20. Maldonaldo Y.A. Current controversies in vaccination. Vaccine 2002, 288:3155-3158.
21. Fenichel G.M. Neurological complications of immunization. Ann Neurol 1982, 12:119-128.
22. Chen R.T., Pless R., DeStefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 2001, 16:309-318.
23. Schattner A. Consequence or coincidence?: the occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005, 23:3876-3886.
24. Vial T., Descotes J. Autoimmune diseases and vaccinations. Eur J Dermatol 2004, 14:86-90.
25. Stratton K.R., Howe C.J., Johnston R.B. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA 1994, 271:1602-1605.
26. Salemi S., D'Amelio R. Could autoimmunity be induced by vaccination?. Int Rev Immunol 2010, 29:247-249.
27. Shoenfeld Y., Aron-Maor A. Vaccination and autoimmunity - 'vaccinosis': a dangerous liaison?. J Autoimmun 2000, 14:1-10.
28. Yen M.Y., Liu J.H. Bilateral optic neuritis following bacille Calmette-Guérin (BCG) vaccination. J Clin Neuroophthalmol 1991, 11:246-249.
29. Hegde V., Dean F. Bilateral panuveitis and optic neuritis following Bacillus Calmette-Guérin (BCG) vaccination. Acta Paediatr 2005, 94:635-636.
30. Topaloglu H., Berker M., Kansu T., Saatci U., Renda Y. Optic neuritis and myelitis after booster tetanus toxoid vaccination. Lancet 1992, 339:178-179.
31. Kitazawa Y., Warabi Y., Bandoh M., Takahashi T., Matsubara S. Elderly-onset neuromyelitis optica which developed after the diagnosis of prostate adenocarcinoma and relapsed after a 23-valent pneumococcal polysaccharide vaccination. Intern Med 2012, 51:103-107.
32. Laria C., Allo J., Rodriguez J.L., Sånchez J., Galal A. Optic neuritis after meningococcal vaccination. Arch Soc Esp Oftalmol 2006, 81:479-482.
33. Kerrison J.B., Lounsbury D., Thirkill C.E., Lane R.G., Schatz M.P., Engler R.M. Optic neuritis after anthrax vaccination. Ophthalmology 2002, 109:99-104.
34. Payne D.C., Rose C.E., Kerrison J., Aranas A., Duderstadt S., McNell M.M. Anthrax vaccination and risk of optic neuritis in the United states military, 1998-2003. Arch Neurol 2006, 63:871-875.
35. Pillar G., Toubi E. Vaccination-induced bilateral optic neuritis: rare but existing. Isr Med Assoc J 2012, 14:690-691.
36. Cormack H.S., Anderson L.A. Bilateral papillitis following antirabic inoculation: recovery. Br J Ophthalmol 1934, 18:167-168.
37. McReynolds W.U., Havender W.H., Petrohelos M.A. Bilateral optic neuritis following smallpox vaccination and diphtheria-tetanus toxoid. AMA Am J Dis Child 1953, 86:601-603.
38. Consul B.N., Purohit G.K., Chhabra H.N. Antirabic vaccine optic neuritis. Indian J Med Sci 1968, 22:630632.
39. Srisupan V., Konyama K. Bilateral retrobulbar optic neuritis following antirabic vaccination. Siriraj Hosp Gaz 1970, 4:403-408.
40. Wells C.E. A neurological note on vaccination against influenza. Br Med J 1971, 3:755-756.
41. Thomas C., Canton P., Raspiller A., Delaveuve J. Papillitis, a complication of rabies vaccination. Bull Soc Ophtalmol Fr 1972, 72:129-132.
42. Chayakul V., Ishikawa S., Chotibut S., Konyama K., Lakanapichonchat T. Convergence insufficiency and optic neuritis due to antirabies inoculation - a case study. Jpn J Ophthalmol 1975, 19:307-314.
43. Bienfang D.C., Kantrowitz F.G., Noble J.L., Raynor A.M. Ocular abnormalities after influenza immunization. Arch Ophthalmol 1977, 95:1649.
44. Kazarian E.L., Gager W.E. Optic neuritis complicating measles, mumps, and rubella vaccination. Am J Ophthalmol 1978, 86:544-547.
45. Perry H.D., Mallen F.J., Grodin R.W., Cossari A.J. Reversible blindness in optic neuritis associated with influenza vaccination. Ann Ophthalmol 1979, 11:545-550.
46. Cangemi F.E., Bergen R.L. Optic atrophy following swine flu vaccination. Ann Ophthalmol 1980, 12:857-863.
47. Kline L.B., Margulies S.L., Oh S.J. Optic neuritis and myelitis following rubella vaccination. Arch Neurol 1982, 39:443-444.
48. Macoul K.L. Bilateral optic atrophy and blindness following swine influenza vaccination. Ann Ophthalmol 1982, 14:398-399.
49. Van de Geijn E.J., Tukkie R., van Phillips L.A., Punt H. Bilateral optic neuritis with branch retinal artery occlusion associated with vaccination. Doc Ophthalmol 1994, 86:403-408.
50. Berkman N., Benzarti T., Dhoui R., Mouly P. Bilateral neuro-papillitis after hepatitis B vaccination. Presse Med 1996, 25:1301.
51. Ray C.L., Dreizin I.J. Bilateral optic neuropathy associated with influenza vaccination. J Neuroophthalmol 1996, 16:182-184.
52. Stevenson V.L., Acheson J.F., Ball J., Plant G.T. Optic neuritis following measles/rubella vaccination in two 13-year-old children. Br J Ophthalmol 1996, 80:1110-1111.
53. Albitar S., Bourgeon B., Genin R., Fen-Chong M., N'Guyen P., Serveaux M.O., et al. Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrol Dial Transplant 1997, 12:2169-2170.
54. Hull T.P., Bates J.H. Optic neuritis after influenza vaccination. Am J Ophthalmol 1997, 124:703-705.
55. Kawasaki A., Purvin V.A., Tang R. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J Neuroophthalmol 1998, 18:56-59.
56. Fledelius H.C. Unilateral papilloedema after hepatitis B vaccination in a migraine patient. Acta Ophthalmol Scand 1999, 77:722-724.
57. Stewart O., Chang B., Bradbury J. Simultaneous administration of hepatitis B and polio vaccines associated with bilateral optic neuritis. Br J Ophthalmol 1999, 83:1200-1201.
58. Burkhard C., Choi M., Wilhelm H. Optic neuritis as a complication in preventative tetanus-diphtheria-poliomyelitis vaccination: a case report. Klin Monbl Augenheilkd 2001, 218:51-54.
59. Voigt U., Baum U., Behrendt W., Hegemann S., Terborg C., Strobel J. Neuritis of the optic nerve after vaccinations against hepatitis a, hepatitis B and yellow fever. Klin Monbl Augenheilkd 2001, 218:688-690.
60. Arshi S., Sadeghi-bazargani H., Ojaghi H., Savadi-Oskouei D., Hekmat S., Jastan M., et al. The first rapid onset optic neuritis after measles-rubella vaccination: case report. Vaccine 2004, 22:3240-3242.
61. Dadeya S., Guliani B.P., Gupta V.S., Malik K.P., Jain D.C. Retrobulbar neuritis following rabies vaccination. Trop Doct 2004, 34:174-175.
62. Gupta V., Bandyopadhyay S., Bapuraj J.R., Gupta A. Bilateral optic neuritis complicating rabies vaccination. Retina 2004, 24:179-181.
63. Moradian S., Ahmadieh H. Early onset optic neuritis following measles-rubella vaccination. J Ophthalmic Vis Res 2008, 3:118-122.
64. Erguven M., Guven S., Akyuz U., Bilgiç, Laloglu F. Optic neuritis following hepatitis B vaccination in a 9-year-old girl. J Chin Med Assoc 2009, 72:594-597.
65. Huang E.H., Lim S.A., Lim P.L., Leo Y.S. Retrobulbar optic neuritis after hepatitis A vaccination in a HIV-infected patient. Eye (Lond) 2009, 23:2267-2271.
66. DiMario F.J., Hajjar M., Cielsielski T. A 16-year-old girl with bilateral visual loss and left hemiparesis following an immunization against human papilloma virus. J Child Neurol 2010, 25:321-327.
67. Tan F.U., Akarsu C., Gullu R., Kansu T. Bilateral optic neuritis after influenza vaccination. Neuro-ophthalmology 2010, 34:115-117.
68. Lapphra K., Huh L., Scheifele D.W. Adverse neurologic reactions after both doses of pandemic H1N1 infuenza vaccine with optic neuritis and demyelination. Pediatr Infect Dis J 2011, 30:84-86.
69. Crawford C., Grasko M.B., Raymond W.R., Rivera B.A., Munson P.D. Reversible blindness in bilateral optic neuritis associated with nasal flu vaccine. Binocul Vis Strabology Q Simms Romano 2012, 27:171-173.
70. Rubinov A., Beiran I., Krasnitz I., Miller B. Bilateral optic neuritis after inactivated influenza vaccination. Isr Med Assoc J 2012, 14:705-707.
71. Menge T., Cree B., Saleh A., Waterboer T., Berthele A., Kalluri S.R., et al. Neuromyelitis optica following human papillomavirus vaccination. Neurology 2012, 79:285-287.
72. Furakawa Y., Komai K., Yamada M. Neuromyelitis optica after Japanese Encephalitis vaccination. Eur J Neurol 2011, 18:e26-e27.
73. Yamasaki K., Horiuchi I., Minohora M., Kawano Y., Ohyagi Y., Yamada T., et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis. Clinical, neuroimaging and immunogenetic studies. Brain 1999, 122:1689-1696.
74. Wingerchuk D., Lennon V.A., Pittock S.J., Luchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
75. Sellner J., Hemmer B., Muhlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun 2010, 34:371-379.
76. Saxena R., Sethi H.S., Rai H.K., Menon V. Bilateral neuro-retinitis following chick embryo cell anti-rabies vaccination - a case report. BMC Ophthalmol 2005, 5:20.
77. Charkoudian L.D., Kaiser G.M., Steinmetz R.L., Srivastava S.K. Acute retinal necrosis after herpes zoster vaccination. Arch Ophthalmol 2011, 129:1495-1497.
78. Rothova A., de Groot J.D., Mudrikova T. Reactivation of acute retinal necrosis after flu H1N1 vaccination. Br J Ophthalmol 2011, 95:291.
79. Gonzales J.A., Levison A.L., Stewart J.M., Acharya N.R., Margolis T.P. Retinal necrosis following varicella-zoster vaccination. Arch Ophthalmol 2012, 130:1355-1356.
80. Miller F.W., Hess E.V., Clauw D.J., Hertzman P.A., Pincus T., Silver R.M., et al. Approaches to identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 2000, 43:243-249.
81. Agmon-Levin N., Kivity S., Szyper-Kravitz M., Shoenfeld Y. Transverse myelitis and vaccines: a multi-analysis. Lupus 2009, 18:1198-1204.
82. Vandenbroucke J.P. In defense of case reports and case series. Ann Intern Med 2001, 134:330-334.
83. Noordzij M., Dekker F.W., Zoccali C., Jager K.J. Study design in clinical research. Nephron Clin Pract 2009, 113:c218-c221.
84. Riikonen R. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children. Acta Neurol Scand 1989, 80:425-431.
85. Riikonen R., Donner M., Erkkila H. Optic neuritis in children with special reference to its relationship to multiple sclerosis. A clinical study of 21 children. Dev Med Child Neurol 1988, 30:349-359.
86. Roussat B., Gohier P., Doummar D., Iba-Zizen M.T., Barbat V., Jarry D., et al. Acute optic neuritis in children: clinical features and treatment. A study of 28 eyes in 20 children. J Fr Ophthalmol 2001, 24:36-44.
87. DeStefano F., Verstraeten T., Jackson L.A., Okoro C.A., Benson P., Black S.B., et al. Vaccinations and risk of central nervous system demyelinating disease in adults. Arch Neurol 2003, 60:504-509.
88. Nass M. Data vs. conclusions in the optic neuritis vaccination investigation. Arch Neurol 2006, 63:1809-1810.
89. Engler R.J., Klote M., Nelson M.R. Optic neuritis and vaccination investigation: failure to consider significant sex differences and multiple vaccine combinations. Arch Neurol 2007, 64:1673-1674.
90. Stratton K., Ford A., Rusch E., Clayton E.W. Adverse effects of vaccines: evidence and causality 2012, 435-504. The National Academy Press, Washington, DC.
91. Mikaeloff Y., Caridade G., Suissa S., Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009, 72:873-880.
92. Varricchio F., Iskander J., Destefano F., Ball R., Pless R., Braun M.M., et al. Understanding vaccine safety information from the vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004, 23:287-294.
93. Shaw F.E., Graham D.J., Guess H.A., Milstein J.B., Johnson J.M., Schatz G.C., et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience in the first three years. Am J Epidemiol 1988, 127:337-352.
94. Geier M.R., Geier D.A. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 2004, 22:749-755.
95. Geier D.A., Geier M.R. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 2005, 38:295-301.
96. Woo E.J., Miller N.B., Ball R., VAERS Working Group Adverse events after hepatitis A B combination vaccine. Vaccine 2006, 24:2685-2691.
97. Liang X.F., Li L., Liu D.W., Li K.L., Wu W.D., Zhu B.P., et al. Safety of influenza A (H1N1) vaccine in post-marketing surveillance in China. N Eng J Med 2011, 364:638-647.
98. Lim S.A., Wong W.L., Fu E., Goh K.Y., Seah A., Tan C., et al. The incidence of neuro-ophthalmic diseases in Singapore: a prospective study in public hospitals. Ophthalmic Epidemiol 2009, 16:65-73.
99. Williams S.E., Pahud B.A., Vellozzi C., Donofrio P.D., Dekker C.L., Halsey N., et al. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine 2011, 29:8302-8308.
100. Nader P.R., Warren R.J. Reported neurological disorders following live measles vaccine. Pediatrics 1968, 41:997-1001.
101. Landrigan P.J., Witte J.J. Neurologic disorders following live measles-virus vaccination. JAMA 1973, 223:1459-1462.
102. Borja-Hart N.L., Benavides S., Christensen C. Human papillomavirus vaccine safety in pediatric patients: an evaluation of the Vaccine Adverse Events Reporting System. Ann Pharmacother 2009, 43:356-359.
103. Olson J.K., Croxford J.L., Miller S.D. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol 2001, 14:227-250.
104. Tishler M., Shoenfeld Y. Vaccination may be associated with autoimmune diseases. Isr Med Assoc J 2004, 6:430-432.
105. Maya R., Gershwin M.E., Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 2008, 34:85-102.
106. Agmon-Levin N., Paz Z., Israeli E., Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009, 5:648-652.
107. Fujinami R.S., von Herrath M.G., Christen U., Whitton J.L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006, 9:80-94.
108. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch K.L., Neville Y., et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997, 3:1133-1136.
109. McCoy L., Tsunoda I., Fujinami R.S. Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 2006, 39:9-19.
110. Barnaba V. Viruses, hidden self-epitopes and autoimmunity. Immunol Rev 1996, 152:47-66.
111. Nahill S.R., Welsh R.M. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J Exp Med 1993, 177:710-715.
112. Kotzin B.L., Leung J., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv Immunol 1993, 54:99-166.
113. Wucherpfennig K.W. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001, 108:1097-1104.
114. Ferri C., Zignego A. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr Opin Rheumatol 2000, 12:53-60.
115. Lavi E., Suzumura A., Murray E.M., Silberberg D.H., Weiss S.R. Induction of MHC class I antigens on glial cells is dependent on persistent mouse hepatitis virus infection. J Neuroimmunol 1989, 22:107-111.
116. Brickman C.M., Shoenfeld Y. The mosaic of autoimmunity. Scand J Clin Lab Invest Suppl 2001, 235:3-15.
117. Santoro D., Vita G., Vita R., Mallamace A., Savica V., Bellinghieri G., et al. HLA haplotype in a patient with systemic lupus erythematosus triggered by hepatitis B vaccine. Clin Nephrol 2010, 74:150-153.
118. Shoenfeld Y., Agmon-Levin N. 'ASIA'-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011, 36:4-8.
119. Meroni P.L. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truths and new syndrome?. J Autoimmun 2011, 36:1-3.
120. Agmon-Levin N., Hughes G.R., Shoenfeld Y. The spectrum of ASIA: 'Autoimmune (Autoinflammatory) Syndrome' induced by adjuvants. Lupus 2012, 21:118-120.
121. Gavin A.L., Hoebe K., Duong B., Ota T., Martin C., Beutler B., et al. Adjuvant-enhanced antibody response in the absence of toll-like receptor signaling. Science 2006, 314:1936-1938.
122. Israeli E., Agmon-Levin N., Blank M., Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009, 18:1217-1225.
123. Cohen A.D., Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 1996, 9:699-703.
124. Schijns V.E. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 2000, 12:456-463.
125. Shoenfeld Y., Aharon-Maor A., Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol 2000, 18:181-184.
126. Geier M.R., Geier D.A., Zahalsky A.C. A review of hepatitis B vaccination. Expert Opin Drug Saf 2003, 2:113-122.